NEW YORK (GenomeWeb News) – Kevin Hrusovsky is resigning his post at PerkinElmer as senior VP and president of the Life Science and Technology division.

Hrusovsky will serve as a consultant to the company for up to one year, beginning in June.

Hrusovsky came to PerkinElmer through the company's acquisition of Caliper Life Sciences, where he was CEO and president.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: gene fusion in premature ovarian failure, population patterns in the Franciscana dolphin, and more.

A National Science Foundation-funded project aims to give researchers access to a network many times faster than the Internet.

Bioethicists weigh the idea of charging patients to take part in clinical research, coming down against the approach.

Cornell's Christopher Mason and his colleagues correct their New York City microbiome study to emphasize "the difference between matching fragments of DNA from a species and a pathogen."